Overview

Kyle practises corporate and securities law, including public and private company financings, mergers and acquisitions, and corporate reorganizations. He also advises clients in connection with securities law compliance, disclosure obligations, stock exchange matters, corporate governance and general corporate law. Kyle represents clients in a broad range of industries including life sciences, technology and mining.

enGene in connection with its US$138-million de-SPAC merger with Forbion European Acquisition

Neovasc in connection with its acquisition by Shockwave for approximately US$100-million

NioCorp Developments Ltd. on its business combination with GX Acquisition Corp. II, a US special purpose acquisition corporation (SPAC), and concurrent financings valued at up to US$71.9-million

Trilogy International Partners in connection with the sale of its subsidiary, Two Degrees, for NZ$1.315-billion

Trillium Therapeutics Inc. in connection with its acquisition by Pfizer for US$2.22-billion

Absolute Software Corporation in connection with its US$340-million acquisition of NetMotion Software, Inc.

CRH Medical Corporation in connection with its acquisition by Well Health Technologies Corp. in a deal valued at US$372.9-million

Practice Areas

• Corporate Law
• Securities

Bar Information

Called to the bar: 2011 (BC)

Downloads

• vCard on firm website